University of Oxford, Department of Statistics logo
University of Oxford, Department of Statistics logo
To Department of Statistics Site

Publications

Holmes, C. and Denison, D. (2003) “Classification with Bayesian MARS”, Machine Learning, 50(1-2), pp. 159–173.
Saphire, E. et al. (2002) “Crystal structure of an intact human IgG: Antibody asymmetry, flexibility, and a guide for HIV-1 vaccine design”, in Advances in Experimental Medicine and Biology. Springer Nature, pp. 55–66.
Rosenfeld, R. et al. (2002) “Conformational Changes in Nitric Oxide Synthases Induced by Chlorzoxazone and Nitroindazoles: Crystallographic and Computational Analyses of Inhibitor Potency †”, Biochemistry, 41(47), pp. 13915–13925.
Nicholson, G. et al. (2002) “Assessing population differentiation and isolation from single‐nucleotide polymorphism data”, in Journal of the Royal Statistical Society Series B (Statistical Methodology). Oxford University Press (OUP), pp. 695–715.
Holmes, C., Denison, D. and Mallick, B. (2002) “Accounting for Model Uncertainty in Seemingly Unrelated Regressions”, Journal of Computational and Graphical Statistics, 11(3), pp. 533–551.
Legge, G. et al. (2002) “Model of the αLβ2 integrin I‐domain/ICAM‐1 DI interface suggests that subtle changes in loop orientation determine ligand specificity”, Proteins Structure Function and Bioinformatics, 48(2), pp. 151–160.
Stoffler, D. et al. (2002) “Evolutionary analysis of HIV‐1 protease inhibitors: Methods for design of inhibitors that evade resistance”, Proteins Structure Function and Bioinformatics, 48(1), pp. 63–74.
Guglielmi, A., Holmes, C. and Walker, S. (2002) “Perfect Simulation Involving Functionals of a Dirichlet Process”, Journal of Computational and Graphical Statistics, 11(2), pp. 306–310.
Holmes, C. and Adams, N. (2002) “A probabilistic nearest neighbour method for statistical pattern recognition”, Journal of the Royal Statistical Society Series B (Statistical Methodology), 64(2), pp. 295–306.
Beck, Z., Morris, G. and Elder, J. (2002) “Defining HIV-1 protease substrate selectivity.”, Infectious Disorders - Drug Targets, 2(1), pp. 37–50.